The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Techne Corp.

  • TECH
  • NASDAQ
  • Consumer Products
  • Latest 67.96
  • Currency US$
  • Change -0.04
  • Percent Change -0.059 %
  • Volume 8,897
  • Wed May 22, 2013 10:10 AM EDT NASDAQ data delayed 15 minutes.
  • Open 68.06
  • Previous Close 68.00
  • High 68.06
  • Low 67.84
  • Bidx2 67.85
  • Askx1 67.98
  • 52-week High 07/02 76.02
  • 52-week Low 04/30 62.55
  • Beta 0.593
  • Market Cap 2,503.65M
  • EPS 3.03
  • P/E 22.40
  • Forward P/E 20.594
  • PEG 1.70
  • Annual Dividend 1.20
  • Yield 1.766

News

Financials & Calendars

Income Statement

  • Sales $309,780,000
  • Earnings $111,390,000
  • Return on Equity 15.75%

Cash Flow

  • Cash Flow --
  • Cash $150,710,000
  • Current Ratio 12.01

12 months ended Mar 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $760,290,000
  • Liabilities $40,780,000
  • Liabilities-to-Equity Ratio 0.06

Price Ratios

  • Price to Sales 8.07
  • Price to Book 3.48
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 30 $0.89 Aug 6 $0.84
Surprises Apr 30 -1.12% n/a n/a
Dividends May 8 $0.30 n/a n/a
Splits n/a -- n/a n/a

12 months ended May 22, 2013.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Techne Corporation is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. and R&D Systems Europe Ltd. Research and Diagnostic Systems, Inc. is a specialty manufacturer of biological products. R&D Europe distributes Research and Diagnostic Systems' biotechnology products in Europe. Its two major operating segments are hematology controls, which are used in hospital and clinical laboratories to check the accuracy of blood analysis instruments, and biotechnology products including purified proteins and antibodies.

Related Securities
Symbol Type Latest % Chg

Officers

  • Thomas E. Oland Chairman of the Board;Chairman
  • Dr. Roger C. Lucas Vice Chairman and Director
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

614 MCKINLEY PL N E
MINNEAPOLIS, MN
55413

Phone: 6123798854
Fax: (612)-3796580

techinfo@techne-corp.com
www.techne-corp.com

Ideas & Discussion

Live Discussion of TECH on StockTwits